TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

123.90$ -0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 7,873 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INCY
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
6,388 6,782 7,136 4,662 5,012 5,444 5,749 5,821 6,330 6,958 7,339 7,873
4,403 4,645 4,849 2,567 2,809 3,239 3,507 3,644 4,278 5,024 5,484 6,119
3,227 3,213 3,346 987 1,304 1,688 1,942 1,955 2,455 3,098 3,461 3,982
3,516 3,656 3,851 1,519 1,775 2,158 2,409 2,422 2,930 3,581 4,016 4,536
657 744 746 739 758 853 823 843 896 1,024 1,051 1,125
57 63 64 101 70 59 64 83 83 101 116 113
156 156 156 156 156 156 156 156 156 133 133 133
129 124 118 114 120 114 108 126 119 117 110 103
1,457 1,592 1,741 1,665 1,841 1,997 2,082 1,650 1,679 1,803 1,787 1,528
1,125 1,240 1,396 1,337 1,502 1,642 1,720 1,279 1,339 1,515 1,490 1,312
9.2 9.1 8.5 8.8 8.3 10 10 11 10 10 4.4 9.8
139 110 164 148 179 197 196 241 172 210 229 250
– 29 29 29 28 34 – – – – – –
4,931 5,190 5,394 2,997 3,171 3,448 3,668 4,171 4,651 5,167 5,552 6,344
-41 160 330 -1,380 -1,274 -1,073 -915 -510 -86 214 517 1,103
226 226 227 218 196 197 198 199 201 205 207 208

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?